• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在健康年轻人群中应用各种干眼管理方案后泪膜稳定性和泪液量的短期变化

Short-Term Changes in Tear Film Stability and Tear Volume Following the Application of Various DED Management Options in a Healthy Young Population.

作者信息

Sabucedo-Villamarin Belén, Garcia-Queiruga Jacobo, Cacabelos-Torres Laura, Giraldez Maria J, Yebra-Pimentel Eva, Pena-Verdeal Hugo

机构信息

GI-2092-Optometry, Departamento de Fisica Aplicada (Area de Optometria), Universidade de Santiago de Compostela, Campus Vida s/n, 15701 Santiago de Compostela, Spain.

Instituto de Investigacion Sanitaria (IDIS), Travesia da Choupana S/N, 15701 Santiago de Compostela, Spain.

出版信息

J Pers Med. 2025 Apr 27;15(5):173. doi: 10.3390/jpm15050173.

DOI:10.3390/jpm15050173
PMID:40423045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12112829/
Abstract

To determine short-term changes in tear film volume and stability after various treatments for dry eye disease in healthy participants. 36 healthy participants aged from 18 to 35 years were recruited for a single-session examination and randomly assigned to one of three treatment groups (1:1:1 treatment, 1:1 eye): Group 1 (artificial tears 'Comfort Drops'), Group 2 (eyelid wipes 'Systane Lid Wipes'), and Group 3 (ocular bath 'Acuaiss'). Tear Meniscus Height (TMH) was assessed at baseline, 2, 5, 10, 15, and 20 min, and Non-Invasive Break-Up Time (NIBUT) at baseline, 2, 10, and 20 min, all using the OCULUS Keratograph 5M by one examiner. Of the initially recruited participants, 35 were analyzed; one was excluded for reflex tearing. Group 1 (n = 12) showed a significant TMH increase at 2 min compared to 10 and 20 min (Friedman, = 0.004; Bonferroni, ≤ 0.028). Group 3 (n = 12) showed a significant increase at 2 and 5 min compared to baseline and decrease at 10 min against 2 and 5 min (Friedman, < 0.001; Bonferroni, ≤ 0.034). Group 2 (n = 11) showed no significant changes over time (Friedman, = 0.108). NIBUT showed no significant differences at any time-point in any group (Friedman, ≥ 0.231). Basal TMH differed between groups (ANOVA, = 0.048), but post hoc analysis found no significance (Bonferroni, all ≥ 0.088). No significant differences in TMH at other time-points (Kruskal-Wallis/ANOVA, ≥ 0.265) or in NIBUT between groups (Kruskal-Wallis/ANOVA, = 0.108) were found. : In healthy participants, artificial tears and ocular baths temporarily increase TMH, while eyelid wipes do not. Neither has an immediate impact on NIBUT.

摘要

为确定健康参与者干眼症经各种治疗后泪膜体积和稳定性的短期变化。招募了36名年龄在18至35岁的健康参与者进行单节段检查,并随机分配到三个治疗组之一(1:1:1治疗,1:1眼):第1组(人工泪液“舒适滴眼液”)、第2组(眼睑擦拭“思然眼睑擦拭巾”)和第3组(眼部冲洗“爱可丽思”)。由一名检查人员使用OCULUS Keratograph 5M在基线、2分钟、5分钟、10分钟、15分钟和20分钟时评估泪河高度(TMH),并在基线、2分钟、10分钟和20分钟时评估非侵入性泪膜破裂时间(NIBUT)。在最初招募的参与者中,对35人进行了分析;1人因反射性流泪被排除。第1组(n = 12)与10分钟和20分钟相比,在2分钟时TMH显著增加(弗里德曼检验,P = 0.004;邦费罗尼检验,P ≤ 0.028)。第3组(n = 12)与基线相比,在2分钟和5分钟时显著增加,与2分钟和5分钟相比,在10分钟时下降(弗里德曼检验,P < 0.001;邦费罗尼检验,P ≤ 0.034)。第2组(n = 11)随时间未显示出显著变化(弗里德曼检验,P = 0.108)。在任何组的任何时间点,NIBUT均未显示出显著差异(弗里德曼检验,P ≥ 0.231)。各组间基础TMH存在差异(方差分析,P = 0.048),但事后分析未发现显著差异(邦费罗尼检验,所有P ≥ 0.088)。在其他时间点的TMH(克鲁斯卡尔 - 沃利斯检验/方差分析,P ≥ 0.265)或各组间的NIBUT(克鲁斯卡尔 - 沃利斯检验/方差分析,P = 0.108)均未发现显著差异。结论:在健康参与者中,人工泪液和眼部冲洗可暂时增加TMH,而眼睑擦拭则不能。两者对NIBUT均无即时影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1007/12112829/cf0ad56b94ab/jpm-15-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1007/12112829/f6e604e38401/jpm-15-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1007/12112829/cf0ad56b94ab/jpm-15-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1007/12112829/f6e604e38401/jpm-15-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1007/12112829/cf0ad56b94ab/jpm-15-00173-g002.jpg

相似文献

1
Short-Term Changes in Tear Film Stability and Tear Volume Following the Application of Various DED Management Options in a Healthy Young Population.在健康年轻人群中应用各种干眼管理方案后泪膜稳定性和泪液量的短期变化
J Pers Med. 2025 Apr 27;15(5):173. doi: 10.3390/jpm15050173.
2
Assessment of tear film parameters post-treatment with commercial eyelid cleaning wipes: a pilot study.使用商用眼睑清洁湿巾治疗后泪膜参数的评估:一项初步研究。
Int J Ophthalmol. 2024 Apr 18;17(4):659-664. doi: 10.18240/ijo.2024.04.08. eCollection 2024.
3
[Evaluation of tear film and meibomian gland function in dry eye patients using Keratograph 5M].[使用角膜地形图仪5M评估干眼患者的泪膜和睑板腺功能]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 May 25;45(4):422-428. doi: 10.3785/j.issn.1008-9292.2016.07.14.
4
Effect of different artificial tears on tear film parameters in dry eye disease.不同人工泪液对干眼症患者泪膜参数的影响。
Optom Vis Sci. 2025 Jan 1;102(1):37-43. doi: 10.1097/OPX.0000000000002206. Epub 2024 Dec 24.
5
Tear meniscus height comparison between AS-OCT and Oculus Keratograph® K5M.AS-OCT与Oculus Keratograph® K5M之间的泪液半月板高度比较。
Rom J Ophthalmol. 2024 Oct-Dec;68(4):398-403. doi: 10.22336/rjo.2024.72.
6
Comparison of non-invasive and fluorescein tear film break-up time in a 65-year-old Norwegian population: a cross-sectional study.65岁挪威人群中非侵入性与荧光素泪膜破裂时间的比较:一项横断面研究。
BMJ Open. 2025 Apr 10;15(4):e090305. doi: 10.1136/bmjopen-2024-090305.
7
Intrasession repeatability and interobserver reproducibility of ICP Tearscope measurements of tear meniscus height and non-invasive breakup time.泪液半月板高度和无创泪膜破裂时间的眼内压泪液镜测量的会话内重复性和观察者间再现性。
Cont Lens Anterior Eye. 2025 Apr;48(2):102333. doi: 10.1016/j.clae.2024.102333. Epub 2024 Nov 13.
8
Ocular surface parameters repeatability and agreement -A comparison between Keratograph 5M and IDRA.眼表参数重复性和一致性——Keratograph 5M 与 IDRA 的比较。
Cont Lens Anterior Eye. 2024 Dec;47(6):102281. doi: 10.1016/j.clae.2024.102281. Epub 2024 Aug 2.
9
Provocation of the ocular surface to investigate the evaporative pathophysiology of dry eye disease.眼表面激发试验用于研究干眼疾病的蒸发性病理生理学。
Cont Lens Anterior Eye. 2021 Feb;44(1):24-29. doi: 10.1016/j.clae.2020.03.014. Epub 2020 Apr 20.
10
Repeatability of Non-invasive Tear Film Evaluation in Healthy Rabbit Eyes.健康兔眼无创泪膜评估的可重复性。
Curr Eye Res. 2023 Aug;48(8):699-703. doi: 10.1080/02713683.2023.2200915. Epub 2023 Apr 12.

本文引用的文献

1
Intrasession repeatability and interobserver reproducibility of ICP Tearscope measurements of tear meniscus height and non-invasive breakup time.泪液半月板高度和无创泪膜破裂时间的眼内压泪液镜测量的会话内重复性和观察者间再现性。
Cont Lens Anterior Eye. 2025 Apr;48(2):102333. doi: 10.1016/j.clae.2024.102333. Epub 2024 Nov 13.
2
Punctal cautery in dry eye disease: A systematic review.干眼症中的泪点烧灼术:一项系统评价。
Ocul Surf. 2024 Oct;34:235-240. doi: 10.1016/j.jtos.2024.08.006. Epub 2024 Aug 9.
3
Temporal Progression of Entry Factors into the Vicious Circle of Dry Eye in Untreated Sufferers.
未经治疗的干眼症患者进入干眼恶性循环的诱发因素的时间进展
Life (Basel). 2024 Jun 26;14(7):806. doi: 10.3390/life14070806.
4
Efficacy and Safety of Artificial Tears Containing Lipidure and Hypromellose for the Treatment of Moderate Dry Eye Disease in Contact Lens Wearers.脂质体和羟丙甲纤维素人工泪液治疗接触镜佩戴者中度干眼的疗效和安全性。
Medicina (Kaunas). 2024 Feb 8;60(2):287. doi: 10.3390/medicina60020287.
5
Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED.亚洲干眼症(DED)的治疗:短泪膜破裂时间型干眼症的治疗策略
Pharmaceutics. 2023 Nov 5;15(11):2591. doi: 10.3390/pharmaceutics15112591.
6
Eyelid cleaning: Methods, tools, and clinical applications.眼睑清洁:方法、工具和临床应用。
Indian J Ophthalmol. 2023 Dec 1;71(12):3607-3614. doi: 10.4103/IJO.IJO_1457_23. Epub 2023 Nov 20.
7
Surgical Procedures in the Treatment of Dry Eye Disease.手术治疗干眼综合征。
J Ocul Pharmacol Ther. 2023 Dec;39(10):692-698. doi: 10.1089/jop.2023.0063. Epub 2023 Aug 11.
8
Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial.一种无水环孢素 0.1%局部滴眼剂治疗中重度干眼的疗效和安全性:ESSENCE-2 随机临床试验。
JAMA Ophthalmol. 2023 May 1;141(5):459-466. doi: 10.1001/jamaophthalmol.2023.0709.
9
Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey.八个欧洲国家的干眼患者报告的负担和总体影响:一项基于网络的横断面调查。
BMJ Open. 2023 Mar 17;13(3):e067007. doi: 10.1136/bmjopen-2022-067007.
10
Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.干眼症:初级保健临床医生和临床专家的识别和治疗策略。
Ann Med. 2023 Dec;55(1):241-252. doi: 10.1080/07853890.2022.2157477.